IFX — Imaflex Income Statement
0.000.00%
Last trade - 00:00- CA$59.90m
- CA$61.08m
- CA$109.85m
- 95
- 97
- 73
- 99
Annual income statement for Imaflex, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 86.7 | 107 | 112 | 93.6 | 110 |
| Cost of Revenue | |||||
| Gross Profit | 16.6 | 17.4 | 18 | 11 | 18 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 77.3 | 97 | 101 | 90.6 | 102 |
| Operating Profit | 9.42 | 10.5 | 10 | 2.97 | 7.77 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 8.21 | 9.8 | 11 | 0.813 | 8.61 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.35 | 8.37 | 9.13 | 0.509 | 7.46 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.35 | 8.37 | 9.13 | 0.509 | 7.46 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.35 | 8.37 | 9.13 | 0.509 | 7.46 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.127 | 0.162 | 0.176 | 0.012 | 0.15 |